ARCHIVES

Lynch Named Director, Yale Cancer Center

This article is from The Cancer Letter archive.

Vol. 35 No. 08 | February 27, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer PAC Advocated At AACR Meeting

May 23, 1986

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991

Funding Opporunities: Program Announcments

January 15, 1999

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution

April 12, 1985

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003